Back

Direct healthcare costs for individuals with atherosclerotic cardiovascular disease, chronic kidney disease stages 3-4 or both: results from the UK Discover database

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Renal and cardiovascular disease (2) Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Andrew Thompson

Lane Clark & Peacock LLP, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Clinical profiles and echocardiographic changes of cardiac remodeling among kidney transplant patients
Doctor J. Cabrera (Metro Manila, PH)
Abstract Slides Video
Presentation thumbnail
Acute kidney injury in patients presenting with acute coronary syndrome, with and without diabetes mellitus
Doctor M. Shah (Hull, GB)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in chronic kidney failure
Professor R. Januszek (Krakow, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Renal and cardiovascular disease (2)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Healthcare resource utilisation and cost of care of systemic inflammation in individuals with atherosclerotic cardiovascular disease and chronic kidney disease
thumbnail
Congress Presentation
Incidence of major cardiovascular outcomes in patients with chronic kidney disease by severity: a United States population-based study using electronic medical records
thumbnail
Congress Presentation
Systemic inflammation and risk of death in patients with atherosclerotic cardiovascular disease and chronic kidney disease.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources